Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis.

× No keyword cloud information.

7 in total

Review 1. The Prevalence and Management of Systemic Amyloidosis in Western Countries.

Authors: Hans L A Nienhuis; Johan Bijzet; Bouke P C Hazenberg
Journal: Kidney Dis (Basel) Date: 2016-02-25

2. Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature.

Authors: Ju-Yang Jung; Young-Bae Kim; Ji-Won Kim; Chang-Hee Suh; Hyoun-Ah Kim
Journal: Medicine (Baltimore) Date: 2021-08-13 Impact factor: 1.817

Review 3. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.

Authors: Serdal Ugurlu; Aysa Hacioglu; Yasaman Adibnia; Vedat Hamuryudan; Huri Ozdogan
Journal: Orphanet J Rare Dis Date: 2017-05-30 Impact factor: 4.123

Review 4. Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.

Authors: Songkiat Chantarogh; Soamarat Vilaiyuk; Thipwimol Tim-Aroon; Suchin Worawichawong
Journal: BMC Nephrol Date: 2017-05-12 Impact factor: 2.388

Review 5. Course and Prognosis of AA Amyloidosis in Patients with Psoriatic Arthritis: Report of Three Cases from a Single Center Cohort and Review of the Literature.

Authors: Murat Bektaş; Nevzat Koca; Burak Ince; Yasemin Yalçınkaya; Bahar Artım Esen; M Lale Öcal; Ahmet Gül; Murat Inanç
Journal: Mediterr J Rheumatol Date: 2022-06-30

Review 6. Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors.

Authors: Toshio Tanaka; Yoshihiro Hishitani; Atsushi Ogata
Journal: Biologics Date: 2014-04-07

7. Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.

Authors: Masaru Matsui; Satoshi Okayama; Hideo Tsushima; Kenichi Samejima; Tomoko Kanki; Ayako Hasegawa; Katsuhiko Morimoto; Yasuhiro Akai; Masato Takano; Shiro Uemura; Chiho Ohbayashi; Yoshihiko Saito
Journal: Case Rep Nephrol Date: 2014-08-12

7 in total